SearchDictionaryMobileLogin

Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

AuthorsNadera J Sweiss, Michael Jude Welsch, James J Curran, Michael H Ellman (Affiliation: University of Chicago, IL 60637, USA. nsweiss at medicine.bsd.uchicago.edu)
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 53 Issue 5 Pg. 788-91 (Oct 15 2005) ISSN: 0004-3591 United States
PMID16208666 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • infliximab
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal (therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sarcoidosis (complications, drug therapy, pathology)
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)